Ciba Seeks FDA Clarification On Possible Triclosan “Data Gaps”
This article was originally published in The Tan Sheet
Executive Summary
Ciba Specialty Chemicals is seeking a meeting with FDA staff to discuss "outstanding issues" relating to triclosan safety, the company says in a recent letter to the agency